Layla Zulfa

Bridging the Gap: New Support Frameworks Address the Long-Term Physical and Emotional Realities of Breast Cancer Survivorship bridging-the-gap-new-support-frameworks-address-the-long-term-physical-and-emotional-realities-of-breast-cancer-survivorship

Bridging the Gap: New Support Frameworks Address the Long-Term Physical and Emotional Realities of Breast Cancer Survivorship

Layla Zulfa October 23, 2026

TORONTO, ON — As medical advancements continue to improve the survival rates for breast cancer patients, a...

Bridging the Global Data Gap: The WHO’s SCORE Initiative and the Future of Public Health bridging-the-global-data-gap-the-whos-score-initiative-and-the-future-of-public-health

Bridging the Global Data Gap: The WHO’s SCORE Initiative and the Future of Public Health

Layla Zulfa October 23, 2026

Introduction: The Imperative of Information In the wake of the COVID-19 pandemic, the global health community has...

Roche Deepens Strategic Ties with China’s Hansoh Pharma in Landmark $400 Million ADC Collaboration roche-deepens-strategic-ties-with-chinas-hansoh-pharma-in-landmark-400-million-adc-collaboration-1

Roche Deepens Strategic Ties with China’s Hansoh Pharma in Landmark $400 Million ADC Collaboration

Layla Zulfa October 23, 2026

In a move that underscores the shifting geography of pharmaceutical innovation, Roche has announced a massive expansion...

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine the-genomic-frontier-how-the-broad-institute-is-rewriting-the-future-of-medicine

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine

Layla Zulfa October 23, 2026

In the quiet corridors of laboratories in Cambridge, Massachusetts, the future of human health is being coded,...

Beyond the Label: Why Not All Ultra-Processed Foods Are Created Equal in Colorectal Cancer Risk beyond-the-label-why-not-all-ultra-processed-foods-are-created-equal-in-colorectal-cancer-risk

Beyond the Label: Why Not All Ultra-Processed Foods Are Created Equal in Colorectal Cancer Risk

Layla Zulfa October 23, 2026

For decades, the term "ultra-processed food" (UPF) has acted as a nutritional red flag, often synonymous with...

Roche Accelerates Oncology Pipeline Through Strategic $400 Million Hansoh Pharma Partnership roche-accelerates-oncology-pipeline-through-strategic-400-million-hansoh-pharma-partnership

Roche Accelerates Oncology Pipeline Through Strategic $400 Million Hansoh Pharma Partnership

Layla Zulfa October 23, 2026

In a definitive move to secure its future in the high-stakes oncology market, Swiss pharmaceutical giant Roche...

Leading the Future of Plastic Surgery: Dr. Lynn A. Damitz Assumes Presidency of the ASPS leading-the-future-of-plastic-surgery-dr-lynn-a-damitz-assumes-presidency-of-the-asps-1

Leading the Future of Plastic Surgery: Dr. Lynn A. Damitz Assumes Presidency of the ASPS

Layla Zulfa October 23, 2026

HOUSTON – In a significant transition for the global medical community, Lynn A. Damitz, MD, FACS, has...

Roche Doubles Down on Chinese Innovation: A $400 Million Bet on Hansoh Pharma’s ADC Expertise roche-doubles-down-on-chinese-innovation-a-400-million-bet-on-hansoh-pharmas-adc-expertise

Roche Doubles Down on Chinese Innovation: A $400 Million Bet on Hansoh Pharma’s ADC Expertise

Layla Zulfa October 23, 2026

In a strategic move that underscores the shifting landscape of global drug discovery, Roche has solidified its...

Groundbreaking Clinical Trial Launched to Combat Post-Treatment Lyme Disease Syndrome groundbreaking-clinical-trial-launched-to-combat-post-treatment-lyme-disease-syndrome

Groundbreaking Clinical Trial Launched to Combat Post-Treatment Lyme Disease Syndrome

Layla Zulfa October 22, 2026

A novel approach targeting persistent immune dysfunction in PTLDS patients marks a significant step forward in addressing...

Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets breakthrough-in-breast-cancer-research-unveiling-a-novel-mechanism-of-tumor-growth-and-potential-therapeutic-targets

Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets

Layla Zulfa October 21, 2026

Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...

Bridging the Gap: New Support Frameworks Address the Long-Term Physical and Emotional Realities of Breast Cancer Survivorship

Bridging the Global Data Gap: The WHO’s SCORE Initiative and the Future of Public Health

Roche Deepens Strategic Ties with China’s Hansoh Pharma in Landmark $400 Million ADC Collaboration

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine

Beyond the Label: Why Not All Ultra-Processed Foods Are Created Equal in Colorectal Cancer Risk

Roche Accelerates Oncology Pipeline Through Strategic $400 Million Hansoh Pharma Partnership

Leading the Future of Plastic Surgery: Dr. Lynn A. Damitz Assumes Presidency of the ASPS

Roche Doubles Down on Chinese Innovation: A $400 Million Bet on Hansoh Pharma’s ADC Expertise

Groundbreaking Clinical Trial Launched to Combat Post-Treatment Lyme Disease Syndrome

Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets

You may have missed

Unveiling a Cancer’s Deceptive Alliance: OU Research Exposes How Breast Tumors Recruit Nerves to Fuel Growth

Influenza mortality in hospitalised patients affected by vaccination

Beyond the Pink: Demanding Transparency and Tangible Impact in Breast Cancer Awareness Month Campaigns

The Stage IV Stampede: Metastatic Breast Cancer Advocates Descend on Capitol Hill to Demand Legislative Reform